A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summary
Future Cardiology | November 26, 2025 | Volume: 22 | Issue: 2 | Pages: 105-117
10.1080/14796678.2025.2583805
| PMID 41292260